NewsSource: EClinCloud

Scale Basics | Is the Scale You Are Using Copyrighted?

4 min readEClinCloud Editorial Team
Article illustration

Source: EClinCloud. Author: EClinCloud.

Article illustration

ONE

Definition of Scale Copyright



What is scale copyright?

01

Scale


Simply put, a scale is a measurement tool that typically consists of multiple items forming a composite score. Professional medical scales reflect general patterns summarized from extensive clinical practice, are statistically sound, and can be used for purposes such as disease screening and diagnosis.

02

Copyright


Copyright, also referred to as "author's rights," denotes the legal rights held by an author or another party (including a legal entity) over a work. In China, the term of copyright protection is the author's lifetime plus 50 years, expiring on December 31 of the 50th year after the author's death. In the United States, copyright protection can extend for 70 years after the author's death and has been retroactively extended several times; as a result, even works published in 1975 remain under copyright protection today and cannot be used freely.


Article illustration
Article illustration
 

(Click the image to view the answer)


Accordingly, the use of a scale in specific scenarios is protected by law until the copyright protection term expires. 


Article illustrationLet's take an example.


Published in 1975, the MMSE (Brief Cognitive State Assessment Scale, Mini-Mental State Examination) contains items assessing functions such as calculation, memory, language comprehension, visuospatial skills, and orientation, and has been widely used as a de facto standard for cognitive screening (such as screening for Alzheimer's disease).

However, in 2000, the scale's authors—Marshal Folstein, Susan Folstein, and Paul McHugh—transferred the scale's copyright to a specialized company for management to protect their rights. In 2001, that company granted an exclusive license for publishing and distributing the scale to Psychological Assessment Resources to manage its intellectual property. This meant that the Mini-Mental State Examination was removed from the public domain, and users must pay to obtain a license to use it.


TWO

Ways to Obtain Scale Copyright Permission


How users obtain scale copyright permission

01

Identify the Usage Scenario for the Scale


We have summarized four common usage scenarios—see which one applies to you.

1. Using a copyrighted scale in a commercial clinical trial;

2. Referencing a copyrighted scale in an academic paper and publishing it in an academic journal;

3. Using a copyrighted scale in nonprofit clinical academic research;

4. Using a copyrighted scale in a non-commercial clinical trial.

02

Confirm the Scale Version to Use


A scale can have different versions depending on factors such as participant age (children, adolescents, adults) and sex (male, female), and over time it may also undergo content updates. Therefore, confirming the scale version is critical.

03

Copyright ownership and pricing confirmation


That is, it is necessary to determine whether the scale is in the public domain (referring to copyrighted works whose copyright protection term has expired and that have entered the public domain), and whether the Chinese version requires linguistic validation. Because copyright licenses vary, different scales belong to different copyright holders, and different copyright holders have varying requirements for copyright use. For example, the EORTC QLQ-C30 quality of life questionnaire for cancer patients requires purchasing a copyright license, granted per research institution without a time limit, with the license fee purchased in tiers based on participant count (that is, calculated according to the number of enrolled participants). The MMSE-2 Mini-Mental State Examination requires purchasing a copyright license, granted per research institution, and the questionnaires must be printed and mailed by the copyright holder.


Article illustration

Once the three steps above have been determined, you can contact the copyright holder to purchase the scale and obtain authorization for it.

References: [1] Zhang Dongjuan. Copyright and Open Access in Clinical Practice [J/OL]. China Information World (e-Healthcare): 36-37 [2022-03-24]. https://xueshu.baidu.com/usercenter/paper/show?paperid=154c2ceef0ad2c53f302765ab0cac250&site=xueshu_se.

Article illustration

EClinCloud provides you with professional scale management services


EClinCloud has a professional medical team to interpret protocols and confirm the accurate scale version, maintains good working relationships with multiple scale authors and copyright holders with timely responses, and has extensive experience in copyright management—we have also purchased the MMSE and MMSE-2 scales mentioned above for many clients. As an added note, we are also well versed in migrating scales to electronic formats, and our professional eCOA team is always standing by to support you! 



Scan the QR code below

for a free consultation on scale copyright questions


Article illustration


Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.